Sign in to continue:

Saturday, July 25th, 2026

Texas Instruments Q2 2026 Earnings Report: Revenue, Net Income & CHIPS Act Incentives Highlights




Texas Instruments Q2 2026 Financial Report: Detailed Analysis for Investors

Texas Instruments Q2 2026 Financial Results: Key Highlights and Investor Insights

Summary of the Report

Texas Instruments Incorporated (NASDAQ: TXN) has released its quarterly report for the period ended June 30, 2026. This detailed financial disclosure provides a comprehensive view of the company’s performance, operational metrics, and balance sheet, which are crucial for shareholders and potential investors in understanding the firm’s trajectory.

Key Financial Highlights

  • Net Income: For Q2 2026, Texas Instruments delivered a net income of \$1.98 billion, a significant increase from \$1.29 billion in Q2 2025. For the six-month period, net income was \$3.53 billion, up from \$2.47 billion in the previous year.
  • Earnings Per Share (EPS):
    • Basic EPS: \$2.16 for Q2 2026 (\$1.42 in Q2 2025), \$3.85 for six months (\$2.71 in 2025).
    • Diluted EPS: \$2.14 for Q2 2026 (\$1.41 in Q2 2025), \$3.82 for six months (\$2.69 in 2025).
  • Gross Profit: \$4.89 billion for Q2 2026, up from \$4.36 billion in Q2 2025.
  • Operating Expenses:
    • Research & Development: \$527 million for Q2 2026 (\$524 million in Q2 2025), \$1.04 billion for six months (\$1.01 billion in 2025).
    • Selling, General & Administrative: \$490 million for Q2 2026 (\$493 million in Q2 2025), \$981 million for six months (\$982 million in 2025).
  • Income Before Taxes: \$2.24 billion for Q2 2026 (\$1.48 billion in Q2 2025), \$3.95 billion for six months (\$2.97 billion in 2025).
  • Comprehensive Income: \$1.98 billion for Q2 2026 (\$1.29 billion in Q2 2025), \$3.53 billion for six months (\$2.46 billion in 2025).

Balance Sheet Overview

  • Total Assets: \$35.88 billion as of June 30, 2026 (\$34.59 billion as of December 31, 2025).
  • Total Stockholders’ Equity: \$18.01 billion as of June 30, 2026 (\$16.27 billion as of December 31, 2025).
  • Cash & Cash Equivalents: \$3.66 billion as of June 30, 2026 (\$3.38 billion as of December 31, 2025).
  • Retained Earnings: \$53.16 billion as of June 30, 2026 (\$52.24 billion as of December 31, 2025).
  • Treasury Stock: 828 million shares as of June 30, 2026 (834 million shares as of December 31, 2025), valued at \$41.94 billion and \$41.86 billion respectively.

Cash Flow Analysis

  • Net Cash from Operating Activities: Robust performance, supported by strong net income and operating efficiency.
  • Capital Expenditures: Notable investment in capital, suggesting ongoing expansion and innovation in manufacturing and R&D.
  • Stock Compensation: \$236 million for six months ended June 30, 2026, reflecting continued employee incentivization and retention strategies.

Shareholder & Price Sensitive Information

  • EPS Growth: The substantial increase in both basic and diluted EPS is a positive indicator for shareholders and may be price sensitive, as it signals improved profitability and operational leverage.
  • Retained Earnings and Equity Growth: The continued accumulation of retained earnings and expansion in equity base reflect healthy financial management and capacity for future dividends or strategic investment.
  • Treasury Stock Activity: The reduction in treasury stock shares may signal ongoing share repurchase programs, which can benefit shareholders by increasing EPS and supporting share price.
  • Comprehensive Income: Comprehensive income growth is a sign of resilient business performance amidst market fluctuations.
  • No Preferred Stock Issuance: Texas Instruments continues to operate with no preferred stock outstanding, maintaining a straightforward capital structure.
  • Large Accelerated Filer Status: The company remains a large accelerated filer, indicating compliance and robust public reporting, which is critical for institutional investors.
  • Nasdaq Global Select Market Listing: TXN shares continue to trade on Nasdaq, ensuring liquidity and visibility among global investors.

Potential Price-Moving Events

  • Strong Earnings and EPS Growth: The jump in net income and EPS is likely to be viewed favorably by the market, potentially leading to upward price movement.
  • Healthy Balance Sheet: The increase in assets and equity supports Texas Instruments’ ability to invest, pay dividends, and repurchase shares, all of which are shareholder-friendly actions.
  • Capital Expenditure and R&D: Continued investment in R&D and capital expenditures may indicate future growth, innovation, and competitive strength, which can positively affect share value.
  • Treasury Stock Reduction: Ongoing share repurchases may reduce supply and boost share price.

Other Investor Considerations

  • Texas Instruments remains compliant with SEC filing requirements and Interactive Data File submissions, reinforcing transparency and trust.
  • The company is not classified as a shell company, a smaller reporting company, or an emerging growth company, signaling maturity and stability.

Conclusion

Texas Instruments’ Q2 2026 financial report demonstrates robust profitability, strong balance sheet metrics, and ongoing investment in innovation. For investors, these results indicate continued financial strength and a commitment to shareholder value. The substantial growth in net income and EPS, along with active share repurchase programs, are likely to be viewed positively by the market and could drive share price appreciation.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with professional advisors before making any investment decisions. The financial information presented is based on Texas Instruments’ official SEC filings for the period ended June 30, 2026. Market conditions and company performance can change, affecting share prices and investment outcomes.




View TEXAS INSTRUMENTS INC Historical chart here



Healthy Choice Wellness Corp: Organic Grocery, Dietary Supplements, and Wellness Market Strategies

Healthy Choice Wellness Corp. (NYSE American: HCWC) 2025 Ann...

3D Systems Corporation Reports 2025 Financial Results: Revenue, Gross Profit, and Segment Performance Analysis

3D Systems Corporation Reports Q4 and Full Year 2025 Financi...